Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.90 |
---|---|
High | 5.93 |
Low | 5.03 |
Bid | 5.42 |
Offer | 5.63 |
Previous close | 6.50 |
Average volume | 19.61k |
---|---|
Shares outstanding | 29.39m |
Free float | 26.77m |
P/E (TTM) | -- |
Market cap | 3.29m USD |
EPS (TTM) | -1.29 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 16:17 BST.
More ▼
- ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
- ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
- ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
- ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
- ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
- ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
- ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
- ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
- ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
- ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
More ▼